1. Home
  2. Analysis
  3. Prednisolone
  4. Cutaneous-leishmaniasis

Prednisolone and Cutaneous leishmaniasis - a phase IV clinical study of FDA data

Summary:

Cutaneous leishmaniasis is reported as a side effect among people who take Prednisolone (prednisolone), especially for people who are male, 60+ old, also take Amphotericin B, and have Immunodeficiency disorders.

The phase IV clinical study analyzes which people have Cutaneous leishmaniasis when taking Prednisolone. It is created by eHealthMe based on reports of 211,370 people who have side effects when taking Prednisolone from the FDA, and is updated regularly.

What is Prednisolone?

Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 212,675 Prednisolone users. Check the latest studies of Prednisolone.

What is Cutaneous leishmaniasis?

Cutaneous leishmaniasis (infection by leishmaniasis produces ulcers on the exposed parts of the body, such as the face, arms and legs) is found to be associated with 14 drugs and 36 conditions by eHealthMe. Check the latest studies of Cutaneous leishmaniasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

211,370 people reported to have side effects when taking Prednisolone.
Among them, 26 people (0.01%) have Cutaneous leishmaniasis.

Could Prednisolone cause Cutaneous leishmaniasis?

Among these 26 people:

What is the gender of people who have Cutaneous leishmaniasis when taking Prednisolone? *

  • female: 42.31 %
  • male: 57.69 %

What is the age of people who have Cutaneous leishmaniasis when taking Prednisolone? *

  • 0-1: 0.0 %
  • 2-9: 3.85 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 11.54 %
  • 40-49: 23.08 %
  • 50-59: 11.54 %
  • 60+: 50.0 %

What are other drugs people take besides Prednisolone? *

  1. Methotrexate: 3 people, 11.54%
  2. Amphotericin B: 3 people, 11.54%
  3. Mycophenolate Mofetil: 2 people, 7.69%
  4. Minocycline: 2 people, 7.69%
  5. Doxycycline: 2 people, 7.69%
  6. Cyclosporine: 2 people, 7.69%
  7. Orapred: 1 person, 3.85%
  8. Methotrexate Sodium: 1 person, 3.85%
  9. Metformin: 1 person, 3.85%
  10. Ketoconazole: 1 person, 3.85%

What are other side effects people have besides Cutaneous leishmaniasis? *

  1. Visceral Leishmaniasis (black fever): 8 people, 30.77%
  2. Pseudomonal Bacteraemia (p. aeruginosa cause of bacterial infections of the blood): 5 people, 19.23%
  3. Mucocutaneous Leishmaniasis (partial or total destruction of the mucous membranes of the nose, mouth and throat cavities): 5 people, 19.23%
  4. Serratia Bacteraemia (bacterial blood infection): 5 people, 19.23%
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 15.38%
  6. Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 3 people, 11.54%
  7. Epstein-Barr Virus Infection: 3 people, 11.54%
  8. Oral Herpes (viral infection of mouth): 3 people, 11.54%
  9. Cachexia (loss of weight): 3 people, 11.54%
  10. Drug Ineffective: 3 people, 11.54%

What are the existing conditions these people have? *

  1. Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 3 people, 11.54%
  2. Immunodeficiency Disorders: 3 people, 11.54%
  3. Hidradenitis (chronic disease of a type of sweat gland): 2 people, 7.69%
  4. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 7.69%
  5. Visceral Leishmaniasis (black fever): 1 person, 3.85%
  6. Renal Impairment (severely reduced kidney function): 1 person, 3.85%
  7. Mucocutaneous Leishmaniasis (partial or total destruction of the mucous membranes of the nose, mouth and throat cavities): 1 person, 3.85%
  8. High Blood Pressure: 1 person, 3.85%
  9. Diabetes: 1 person, 3.85%
  10. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisolone and have Cutaneous leishmaniasis?

- Check whether Cutaneous leishmaniasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prednisolone:

Cutaneous leishmaniasis treatments and more:

How severe was Cutaneous leishmaniasis and when was it recovered:

Expand to all the drugs that have ingredients of prednisolone:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cutaneous leishmaniasis:

Browse all the conditions that are associated with Cutaneous leishmaniasis:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on prednisolone (the active ingredients of Prednisolone) and Prednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.